NMTC Stock Analysis: Buy, Sell, or Hold?
NMTC - NeuroOne Medical Technologies Corporation Common Stock
$4.60
0.09 (2.00%)
▲
5d:
+1.32%
30d:
+521.54%
90d:
+510.0%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When NMTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called NMTC this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NMTC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: NMTC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NMTC is currently trading at $4.60, which is considered slightly high relative to its 30-day fair value range of $1.82 to $5.32.
Technical Outlook: Technically, NMTC is in a strong uptrend. Immediate support is located at $4.14, while resistance sits at $4.87.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.87 (+158.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NMTC is in a strong uptrend. Immediate support is located at $4.14, while resistance sits at $4.87.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.87 (+158.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.82 -
$5.32
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 158.0% below Wall St target ($11.87)
Trading Range Analysis
30-Day Trading Range
$1.82 -
$5.32
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.14
Resistance Level
$4.87
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.26
Wall Street Target
$11.87
(+158.0%)
Revenue Growth (YoY)
72.5%
Profit Margin
-52.2%
Share & Embed Analysis
Last updated: May 14, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
Data refreshes hourly during market hours. Next update: 6:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NMTC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Christianson
SELL
16 shares
2026-03-13
Mark Christianson
SELL
136 shares
2026-03-12
Mark Christianson
SELL
351 shares
2026-03-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 58 HOLD |
